128 related articles for article (PubMed ID: 29873506)
1. Clinical Evaluation of
Wangerin KA; Baratto L; Khalighi MM; Hope TA; Gulaka PK; Deller TW; Iagaru AH
AJR Am J Roentgenol; 2018 Sep; 211(3):655-660. PubMed ID: 29873506
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Various β Values on Image Quality and Semiquantitative Measurements in 68Ga-RM2 and 68Ga-PSMA-11 PET/MRI Images Reconstructed With a Block Sequential Regularized Expectation Maximization Algorithm.
Baratto L; Duan H; Ferri V; Khalighi M; Iagaru A
Clin Nucl Med; 2020 Jul; 45(7):506-513. PubMed ID: 32433170
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI.
Heußer T; Mann P; Rank CM; Schäfer M; Dimitrakopoulou-Strauss A; Schlemmer HP; Hadaschik BA; Kopka K; Bachert P; Kachelrieß M; Freitag MT
PLoS One; 2017; 12(8):e0183329. PubMed ID: 28817656
[TBL] [Abstract][Full Text] [Related]
4. Reduced Acquisition Time per Bed Position for PET/MRI Using
Duan H; Baratto L; Hatami N; Liang T; Levin CS; Khalighi MM; Iagaru A
AJR Am J Roentgenol; 2022 Feb; 218(2):333-340. PubMed ID: 34406051
[No Abstract] [Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Scatter Artifact with Ga-68-PSMA-11 PET: Severity Reduced With Furosemide Diuresis and Improved Scatter Correction.
Lawhn-Heath C; Flavell RR; Korenchan DE; Deller T; Lake S; Carroll PR; Hope TA
Mol Imaging; 2018; 17():1536012118811741. PubMed ID: 31749411
[TBL] [Abstract][Full Text] [Related]
7. Improving
Lindemann ME; Guberina N; Wetter A; Fendler WP; Jakoby B; Quick HH
J Nucl Med; 2019 Nov; 60(11):1642-1648. PubMed ID: 30979819
[TBL] [Abstract][Full Text] [Related]
8. Pilot Comparison of ⁶⁸Ga-RM2 PET and ⁶⁸Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer.
Minamimoto R; Hancock S; Schneider B; Chin FT; Jamali M; Loening A; Vasanawala S; Gambhir SS; Iagaru A
J Nucl Med; 2016 Apr; 57(4):557-62. PubMed ID: 26659347
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Deep Learning-Guided Attenuation and Scatter Correction of Whole-Body 68Ga-PSMA PET Studies in the Image Domain.
Mostafapour S; Gholamiankhah F; Dadgar H; Arabi H; Zaidi H
Clin Nucl Med; 2021 Aug; 46(8):609-615. PubMed ID: 33661195
[TBL] [Abstract][Full Text] [Related]
10. Whole-Body Integrated [
Guberina N; Hetkamp P; Ruebben H; Fendler W; Grueneisen J; Suntharalingam S; Kirchner J; Puellen L; Harke N; Radtke JP; Umutlu L; Hadaschik BA; Herrmann K; Forsting M; Wetter A
Mol Imaging Biol; 2020 Jun; 22(3):788-796. PubMed ID: 31482413
[TBL] [Abstract][Full Text] [Related]
11. Effects of arm truncation on the appearance of the halo artifact in
Afshar-Oromieh A; Wolf M; Haberkorn U; Kachelrieß M; Gnirs R; Kopka K; Schlemmer HP; Freitag MT
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1636-1646. PubMed ID: 28508120
[TBL] [Abstract][Full Text] [Related]
12. Comparison of maximum likelihood and conventional PET scatter scaling methods for
Bal H; Kiser JW; Conti M; Bowen SL
Med Phys; 2021 Aug; 48(8):4218-4228. PubMed ID: 34013586
[TBL] [Abstract][Full Text] [Related]
13. Frusemide aids diagnostic interpretation of
Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852
[TBL] [Abstract][Full Text] [Related]
14. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
[TBL] [Abstract][Full Text] [Related]
15. Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [
Uprimny C; Bayerschmidt S; Kroiss AS; Fritz J; Nilica B; Svirydenka A; Decristoforo C; di Santo G; von Guggenberg E; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):123-133. PubMed ID: 32385647
[TBL] [Abstract][Full Text] [Related]
16. One-Stop-Shop Whole-Body
Thalgott M; Düwel C; Rauscher I; Heck MM; Haller B; Gafita A; Gschwend JE; Schwaiger M; Maurer T; Eiber M
J Nucl Med; 2018 Dec; 59(12):1850-1856. PubMed ID: 29794224
[TBL] [Abstract][Full Text] [Related]
17. Integrated
Lütje S; Cohnen J; Gomez B; Grüneisen J; Sawicki L; Rübben H; Bockisch A; Umutlu L; Pöppel TD; Wetter A
Nuklearmedizin; 2017 Jun; 56(3):73-81. PubMed ID: 28401244
[TBL] [Abstract][Full Text] [Related]
18. Differential privacy preserved federated transfer learning for multi-institutional
Shiri I; Salimi Y; Maghsudi M; Jenabi E; Harsini S; Razeghi B; Mostafaei S; Hajianfar G; Sanaat A; Jafari E; Samimi R; Khateri M; Sheikhzadeh P; Geramifar P; Dadgar H; Bitrafan Rajabi A; Assadi M; Bénard F; Vafaei Sadr A; Voloshynovskiy S; Mainta I; Uribe C; Rahmim A; Zaidi H
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):40-53. PubMed ID: 37682303
[TBL] [Abstract][Full Text] [Related]
19. Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer.
Park SY; Zacharias C; Harrison C; Fan RE; Kunder C; Hatami N; Giesel F; Ghanouni P; Daniel B; Loening AM; Sonn GA; Iagaru A
Radiology; 2018 Aug; 288(2):495-505. PubMed ID: 29786490
[TBL] [Abstract][Full Text] [Related]
20. Improved Scatter Correction to Eliminate Halo Artifacts for
Wangerin K; Iagaru A
J Nucl Med; 2019 Sep; 60(9):1334. PubMed ID: 31076503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
